Monster Beverage completed a 2-for-1 stock split in August 2026, which roughly halved its share price and reset investor conversations around round-number milestones. Before the split the stock traded near $90, and analyst price targets were quoted in the $80 to $113 range. Adjusted for the split, that consensus now sits near $49, making $50 the natural psychological target — essentially the level at which Monster would reclaim its pre-split high and reach Wall Street's average 12-month objective.
Monster Beverage Corporation is a leading global developer and marketer of energy drinks, with flagship brands that include Monster Energy and a portfolio of juices, teas, and functional beverages distributed through a long-standing partnership with The Coca-Cola Company (KO). The stock trades on the Nasdaq with a market capitalization of roughly $86 billion and a trailing price-to-earnings (P/E) ratio above 35, reflecting its history of consistent, high-quality growth.
The most powerful catalyst is Monster's international expansion. In its fiscal first quarter, net sales rose 26.9% to $2.35 billion — the first time quarterly sales topped $2 billion in a first quarter — while net sales to customers outside the United States jumped 44.9% and represented approximately 45% of the total, a company record. A record second quarter followed, with net sales up about 20% year over year, helped by strength in markets such as Brazil and India.
Wall Street also sees a margin recovery ahead. Morgan Stanley has argued that Monster's earnings growth should outpace revenue growth beginning in 2027, driven by steadier annual pricing, a shift toward higher-margin zero-sugar products, and operating leverage as the business scales. If that margin inflection materializes, it would strengthen the fundamental case for a move toward $50.
Competition remains the clearest obstacle. Celsius Holdings (CELH) has emerged as PepsiCo's (PEP) primary energy drink partner, holding roughly 21% category share in the U.S., while Red Bull remains the global category leader. Monster also faces near-term margin pressure: gross margin slipped to about 55% in its first quarter from 56.5% a year earlier, largely because faster-growing international markets carry lower margins than the U.S.
Valuation is another constraint. At roughly 38 times forward earnings, the stock already prices in meaningful growth, which limits upside if execution or category growth disappoints.
Sentiment among sell-side analysts is broadly positive. Recent coverage has included more Buy ratings than Hold ratings and essentially no Sell ratings. Before the split, the average analyst price target was near $98.65, with a range from $80 to $113; adjusted for the 2-for-1 split, that translates to roughly $49 on average, with the highest estimates near $56. Notably, firms including Morgan Stanley, Stifel, Citi, and Bank of America raised their targets through 2026 following Monster's strong earnings, suggesting the consensus is moving toward, and in several cases above, the $50 mark.
On a split-adjusted basis, Monster has traded within a 52-week range of roughly $31.50 to $50.17. The $50 level therefore functions as both a psychological round number and a prior high, making it a meaningful resistance level. Below the current price, the low-$40s and the mid-$30s represent support zones where buyers have previously stepped in. A sustained move through $50 would require the stock to clear this multi-month ceiling on stronger fundamentals rather than short-term momentum alone.
For traders monitoring whether Monster can build the momentum needed to approach $50, AI Daily Buy/Sell Signals from Tickeron offers an additional layer of analysis. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven evaluation. These signals can help traders discover opportunities, track existing positions, and identify shifting market trends more efficiently than manual screening alone.
A move to $50 is realistic for Monster Beverage, but it is not a foregone conclusion. The case is supported by accelerating international sales, a strong product innovation pipeline, and an analyst consensus that already clusters near that level. The main risks are intensifying competition, near-term gross-margin compression from geographic mix, and a valuation that leaves little cushion. Investors watching the $50 target should monitor international revenue trends, evidence of a margin inflection into 2027, and any shift in the competitive dynamic with Celsius and Red Bull.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MNST has been loosely correlated with CCEP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MNST jumps, then CCEP could also see price increases.
| Ticker / NAME | Correlation To MNST | 1D Price Change % | ||
|---|---|---|---|---|
| MNST | 100% | +1.33% | ||
| CCEP - MNST | 47% Loosely correlated | +0.41% | ||
| KDP - MNST | 38% Loosely correlated | +1.71% | ||
| PEP - MNST | 28% Poorly correlated | -0.19% | ||
| FIZZ - MNST | 26% Poorly correlated | -1.58% | ||
| COCO - MNST | 24% Poorly correlated | -1.16% | ||
More | ||||